{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:18:08Z","timestamp":1773422288694,"version":"3.50.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["smrv-journal.com","mdconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.smrv.2013.07.005","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T16:50:29Z","timestamp":1381337429000},"page":"261-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions"],"prefix":"10.1016","volume":"18","author":[{"given":"Thomas","family":"Roth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley M.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Garcia-Borreguero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malca","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Clair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2013.07.005_bib1","series-title":"Measuring functioning and well being","first-page":"235","article-title":"Sleep measures","author":"Hays","year":"1992"},{"key":"10.1016\/j.smrv.2013.07.005_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.smrv.2013.07.005_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Clin Psychol"},{"key":"10.1016\/j.smrv.2013.07.005_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/187152409787601932","article-title":"Mechanisms and treatment of neuropathic pain","volume":"9","author":"Vranken","year":"2009","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1016\/j.smrv.2013.07.005_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0168-8227(99)00112-6","article-title":"Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life","volume":"47","author":"Galer","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.smrv.2013.07.005_bib6","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1053\/apmr.2001.26068","article-title":"Chronic pain after spinal injury: interference with sleep and daily activities","volume":"82","author":"Widerstrom-Noga","year":"2001","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.smrv.2013.07.005_bib7","first-page":"356","article-title":"Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey","volume":"6","author":"Oster","year":"2005","journal-title":"J\u00a0Pain"},{"issue":"abstract suppl.","key":"10.1016\/j.smrv.2013.07.005_bib8","first-page":"A354","article-title":"Polysomnographic evaluation of sleep disturbance in neuropathic pain","volume":"26","author":"Mundel","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2013.07.005_bib9","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2337\/dc12-0656","article-title":"Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life","volume":"35","author":"Boyle","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.smrv.2013.07.005_bib10","first-page":"253","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib11","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2013.07.005_bib12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpain.2007.05.003","article-title":"Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study","volume":"12","author":"T\u00f6lle","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-8-33","article-title":"Efficacy and safety of pregabalin 600\u00a0mg\/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial","volume":"8","author":"Arezzo","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1016\/j.smrv.2013.07.005_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1464-5491.2010.03152.x","article-title":"Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14-week randomized, double-blind, placebo-controlled trial","volume":"28","author":"Satoh","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.smrv.2013.07.005_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib17","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2013.07.005_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1185\/030079906X80404","article-title":"Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial","volume":"22","author":"van Seventer","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.smrv.2013.07.005_bib19","first-page":"1006","article-title":"Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief","volume":"9","author":"Stacey","year":"2008","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib20","first-page":"141","article-title":"Evaluation of the efficacy and safety of pregabalin in the treatment of postherpetic neuralgia \u2013 a randomized, double-blind, multicenter, placebo-controlled study","volume":"17","author":"Ogawa","year":"2010","journal-title":"J\u00a0Jpn Soc Pain Clin"},{"key":"10.1016\/j.smrv.2013.07.005_bib21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ejpain.2007.12.004","article-title":"Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: open-label, non-comparative, flexible-dose study","volume":"12","author":"Baron","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clinthera.2011.02.007","article-title":"Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China","volume":"33","author":"Guan","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.smrv.2013.07.005_bib24","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1212\/01.wnl.0000244422.45278.ff","article-title":"Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial","volume":"67","author":"Siddall","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2013.07.005_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1212\/WNL.0b013e318281546b","article-title":"A\u00a0randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury","volume":"80","author":"Cardenas","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2013.07.005_bib26","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00296-009-1086-1","article-title":"Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings","volume":"30","author":"Salda\u00f1a","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.smrv.2013.07.005_bib27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.pain.2010.04.013","article-title":"The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy","volume":"150","author":"Baron","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.pain.2010.12.023","article-title":"Safety and efficacy of pregabalin in patients with central post-stroke pain","volume":"152","author":"Kim","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib29","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1468-1331.2010.02979.x","article-title":"Pregabalin in the treatment of posttraumatic peripheral neuropathic pain: a randomized double-blind trial","volume":"17","author":"van Seventer","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.smrv.2013.07.005_bib30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s12094-011-0711-0","article-title":"Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health","volume":"13","author":"Ma\u0144as","year":"2011","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.smrv.2013.07.005_bib31","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1468-2982.2008.01792.x","article-title":"Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings","volume":"29","author":"Perez","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.smrv.2013.07.005_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.0b013e3181ccc6ef","article-title":"Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial","volume":"74","author":"Simpson","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2013.07.005_bib33","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1742-1241.2010.02389.x","article-title":"A\u00a0prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America","volume":"64","author":"Xochilcal-Morales","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.smrv.2013.07.005_bib34","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.clinthera.2011.01.014","article-title":"The efficacy and safety of pregabalin using a flexible, optimized dose schedule in subjects with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study","volume":"32","author":"Moon","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.smrv.2013.07.005_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2165\/11589370-000000000-00000","article-title":"Impact of pregabalin treatment on pain, pain-related sleep interference and general well-being in patients with neuropathic pain: a non-interventional, multicentre, post-marketing study","volume":"31","author":"Anastassiou","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.smrv.2013.07.005_bib36","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1742-1241.2006.01069.x","article-title":"Pregabalin for peripheral neuropathic pain: results of a multicenter, non-comparative, open-label study in Indian patients","volume":"60","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.smrv.2013.07.005_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/AJP.0b013e3181fe13f6","article-title":"Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial","volume":"27","author":"Gilron","year":"2011","journal-title":"Clin J Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1876386301205010001","article-title":"Pregabalin in neuropathic pain related to DPN, cancer and back pain: analysis of a 6-week observational study","volume":"5","author":"Toelle","year":"2012","journal-title":"Open Pain J"},{"key":"10.1016\/j.smrv.2013.07.005_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/WNF.0b013e31823df2dc","article-title":"Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course","volume":"35","author":"Perez-Lloret","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.smrv.2013.07.005_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-9-17","article-title":"Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic pain","volume":"9","author":"van Seventer","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.smrv.2013.07.005_bib41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.smrv.2013.07.005_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00000441-199806000-00005","article-title":"Sleep in fibromyalgia patients: subjective and objective findings","volume":"315","author":"Harding","year":"1998","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.smrv.2013.07.005_bib43","first-page":"1113","article-title":"Sleep cycles and alpha-delta sleep in fibromyalgia syndrome","volume":"21","author":"Branco","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.smrv.2013.07.005_bib44","first-page":"1193","article-title":"Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?","volume":"31","author":"Rizzi","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.smrv.2013.07.005_bib45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/acr.21595","article-title":"Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study","volume":"64","author":"Roth","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.smrv.2013.07.005_bib46","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.smrv.2013.07.005_bib47","first-page":"502","article-title":"A\u00a0randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia","volume":"35","author":"Mease","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.smrv.2013.07.005_bib48","first-page":"792","article-title":"A\u00a014-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia","volume":"9","author":"Arnold","year":"2008","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.smrv.2013.07.005_bib49","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3899\/jrheum.110569","article-title":"An international, randomised, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in the treatment of patients with fibromyalgia","volume":"38","author":"Pauer","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.smrv.2013.07.005_bib50","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/rheumatology\/kep432","article-title":"Pregabalin in fibromyalgia \u2013 meta-analysis of efficacy and safety from company clinical trial reports","volume":"49","author":"Straube","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.smrv.2013.07.005_bib51","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.sleep.2009.01.009","article-title":"The effect of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome","volume":"10","author":"Russell","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2013.07.005_bib52","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1517\/14656566.2010.509717","article-title":"Treatment response to pregabalin in fibromyalgia: effect of patient baseline characteristics","volume":"11","author":"Emir","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.smrv.2013.07.005_bib53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"Suppl.","key":"10.1016\/j.smrv.2013.07.005_bib54","first-page":"122","article-title":"Restless legs syndrome","volume":"158","author":"Ekbom","year":"1945","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.smrv.2013.07.005_bib55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.sleep.2004.03.006","article-title":"Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study","volume":"5","author":"Hening","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2013.07.005_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/sleep\/30.7.861","article-title":"Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study","volume":"30","author":"Hornyak","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2013.07.005_bib57","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/sleep\/27.5.907","article-title":"Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome","volume":"27","author":"Allen","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2013.07.005_bib58","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1212\/WNL.0b013e3181e1ce73","article-title":"Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study","volume":"74","author":"Garcia-Borreguero","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2013.07.005_bib59","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.sleep.2010.03.003","article-title":"A\u00a0randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome","volume":"11","author":"Allen","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2013.07.005_bib60","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.0013-9580.2004.46703.x","article-title":"Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life","volume":"45","author":"de Weerd","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.smrv.2013.07.005_bib61","first-page":"73","article-title":"Sleep organization and epilepsy","volume":"2","author":"Touchon","year":"1991","journal-title":"Epilepsy Res"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.smrv.2013.07.005_bib62","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.yebeh.2003.07.005","article-title":"Epilepsy and sleep disturbance","volume":"4","author":"Bazil","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.smrv.2013.07.005_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/s1389-9457(02)00217-4","article-title":"Effects of antiepileptic drugs on sleep architecture: a pilot study","volume":"4","author":"Legros","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.smrv.2013.07.005_bib64","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1468-1331.2008.02347.x","article-title":"Pregabalin as add-on therapy induces REM sleep enhancement in partial epilepsy: a polysomnographic study","volume":"16","author":"Romigi","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.smrv.2013.07.005_bib65","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5664\/jcsm.26911","article-title":"Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy","volume":"3","author":"de Haas","year":"2007","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.smrv.2013.07.005_bib66","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.yebeh.2012.02.005","article-title":"Pregabalin increases slow-wave sleep and may improve attention in patients with partial epilepsy and insomnia","volume":"23","author":"Bazil","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.smrv.2013.07.005_bib67","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1528-1167.2008.01954.x","article-title":"Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial","volume":"50","author":"Lee","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.smrv.2013.07.005_bib68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eplepsyres.2012.01.009","article-title":"A\u00a021-week open-label clinical trial of pregabalin as an add-on therapy in partial seizures at multiple centers in Mexico (PREPS Mexico)","volume":"100","author":"Rivera-Casta\u00f1o","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.smrv.2013.07.005_bib69","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.yebeh.2010.08.011","article-title":"Changes in seizures severity and quality of life in patients with refractory partial epilepsy","volume":"19","author":"Sancho","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.smrv.2013.07.005_bib70","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.seizure.2011.06.022","article-title":"An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece","volume":"20","author":"Tsounis","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.smrv.2013.07.005_bib71","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1468-1331.2009.02916.x","article-title":"Pregabalin in partial seizures: a pragmatic 21-week, open-label study (PREPS)","volume":"17","author":"Ryvlin","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.smrv.2013.07.005_bib72","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09540260500104524","article-title":"Sleep disturbance in anxiety disorders","volume":"17","author":"Papadimitriou","year":"2005","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.smrv.2013.07.005_bib73","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpsychires.2006.07.008","article-title":"The association of insomnia with anxiety disorders and depression: exploration of the direction of risk","volume":"40","author":"Johnson","year":"2006","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.smrv.2013.07.005_bib74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/smrv.1999.0096","article-title":"Sleep disturbance in generalized anxiety disorder and its treatment","volume":"4","author":"Monti","year":"2000","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2013.07.005_bib75","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/sleep\/20.5.370","article-title":"Generalized anxiety and sleep architecture: a polysomnographic investigation","volume":"20","author":"Fuller","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2013.07.005_bib76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/YIC.0b013e32831d7980","article-title":"Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial","volume":"24","author":"Kasper","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.smrv.2013.07.005_bib77","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.jcp.0000084032.22282.ff","article-title":"A\u00a0randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder","volume":"23","author":"Feltner","year":"2003","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.smrv.2013.07.005_bib78","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1176\/appi.ajp.160.3.533","article-title":"Pregabalin in generalized anxiety disorder: a placebo-controlled trial","volume":"160","author":"Pande","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.smrv.2013.07.005_bib79","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.jcp.0000155820.74832.b0","article-title":"Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing","volume":"25","author":"Pohl","year":"2005","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.smrv.2013.07.005_bib80","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.62.9.1022","article-title":"Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam","volume":"62","author":"Rickels","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.smrv.2013.07.005_bib81","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4088\/JCP.v67n0511","article-title":"Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine","volume":"67","author":"Montgomery","year":"2006","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.smrv.2013.07.005_bib82","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1192\/bjp.bp.107.037788","article-title":"Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder","volume":"193","author":"Montgomery","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.smrv.2013.07.005_bib83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/YIC.0b013e3282f0f0d7","article-title":"Long-term efficacy of pregabalin in generalized anxiety disorder","volume":"23","author":"Feltner","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.smrv.2013.07.005_bib84","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1461145709990460","article-title":"Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder","volume":"13","author":"Lydiard","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.smrv.2013.07.005_bib85","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/YIC.0b013e32832dceb9","article-title":"Efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia","volume":"24","author":"Montgomery","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.smrv.2013.07.005_bib86","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4321\/S0213-61632010000100003","article-title":"Pregabalin reduces sleep disturbance in patients with generalized anxiety disorder via both direct and indirect mechanisms","volume":"24","author":"Bollu","year":"2010","journal-title":"Eur J Psychiatry"},{"key":"10.1016\/j.smrv.2013.07.005_bib87","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000324850","article-title":"Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use","volume":"17","author":"Rubio","year":"2011","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.smrv.2013.07.005_bib88","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/sleep\/28.2.187","article-title":"A\u00a0double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo","volume":"28","author":"Hindmarch","year":"2005","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2013.07.005_bib89","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.59.10.1573","article-title":"Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study","volume":"59","author":"Garcia-Borreguero","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.smrv.2013.07.005_bib90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/sleep\/32.2.159","article-title":"A\u00a0randomized, double-blind, placebo-controlled, crossover study of XP13512\/GSK1838262 in the treatment of patients with primary restless legs syndrome","volume":"32","author":"Kushida","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2013.07.005_bib91","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/mds.23771","article-title":"Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome","volume":"26","author":"Winkelman","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.smrv.2013.07.005_bib92","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1046\/j.1528-1157.2002.21002.x","article-title":"Gabapentin increases slow-wave sleep in normal adults","volume":"43","author":"Foldvary-Schaefer","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.smrv.2013.07.005_bib93","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/WNF.0b013e3181cda242","article-title":"Treatment effects of gabapentin for primary insomnia","volume":"33","author":"Lo","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.smrv.2013.07.005_bib94","series-title":"Principles and practice of sleep medicine","first-page":"905","article-title":"Pharmacologic treatment of insomnia: benzodiazepine receptor agonists","author":"Walsh","year":"2011"},{"key":"10.1016\/j.smrv.2013.07.005_bib95","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tips.2006.12.006","article-title":"Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission","volume":"28","author":"Dooley","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.smrv.2013.07.005_bib96","unstructured":"Lyrica US prescribing information [online]. Available at: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=561 [accessed 01.07.13]."},{"key":"10.1016\/j.smrv.2013.07.005_bib97","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/AJP.0b013e31823dd315","article-title":"Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin","volume":"7","author":"Pauer","year":"2012","journal-title":"Clin J Pain"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079213000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079213000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T16:06:20Z","timestamp":1596643580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079213000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1087079213000865"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2013.07.005","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2013.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}